Material Agreements

Fold Holdings, Inc. entered into Purchase Agreement with SATS Credit Fund L.P. valued at $13.0 million promissory note and 520,000 shares of Common Stock (effective 2026-02-25).

“Contemporaneously with the termination (as described below) of the March 2025 Note (as defined below), Fold Holdings, Inc. (the "Company") entered into a Purchase Agreement with SATS Credit Fund L.P. ("SATS") dated February 25, 2026 (the "Purchase Agreement"), pursuant to which SATS purchased from the Company a $13.0 million promissory note, repayable in cash (the "New Note") and 520,000 shares of the Company's Common Stock (the "Initial Commitment Shares").”

GE HealthCare Technologies Inc. terminated 2025 364-Day Revolving Credit Agreement with JPMorgan Chase Bank, N.A. and the lenders named therein valued at $0.5 billion (effective 2026-02-26).

“In connection with the Company’s entry into the New Revolving Credit Agreement, the 2025 364-Day Revolving Credit Agreement, which provided for a $0.5 billion 364-day senior unsecured revolving credit facility, was terminated without penalty on February 26, 2026.”

GE HealthCare Technologies Inc. entered into New Revolving Credit Agreement with JPMorgan Chase Bank, N.A. and the lenders named therein valued at $0.5 billion (effective 2026-02-26).

“On February 26, 2026, GE HealthCare Technologies Inc. (the “Company”) entered into a 364-Day Revolving Credit Agreement (the “New Revolving Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $0.5 billion.”

Kinetic Seas Inc. entered into Securities Purchase Agreement with LABRYS FUND II, L.P. valued at $148,500 (effective 2026-02-23).

“On February 23, 2026, Kinetic Seas Incorporated (the “Company”) entered into a Securities Purchase Agreement with LABRYS FUND II, L.P. pursuant to which the Company issued an unsecured promissory note (the “Note”) in the principal amount of $148,500 for gross proceeds of $135,000.”

FrontView REIT, Inc. entered into First Amendment to the Amended and Restated Partnership Agreement of FrontView Operating Partnership LP with FrontView Operating Partnership LP valued at Creation of Series A Convertible Preferred Units with terms substantially similar to Series A Prefer (effective 2026-02-10).

“On February 10, 2026, the Company, as sole general partner of FrontView Operating Partnership LP (the “Operating Partnership”), entered into an amendment (the “OP Amendment”) to the amended and restated partnership agreement of the Operating Partnership (the “Partnership Agreement”).”

FrontView REIT, Inc. entered into Series A Convertible Preferred Stock Purchase with Maewyn FVR II LP, Rebound Investment, LP, Petrus Special Situations Fund, L.P. valued at 250,000 shares of Series A Convertible Preferred Stock at $100.00/share, approximately $25.0 million (effective 2026-02-10).

“On February 10, 2026, the Company, issued an aggregate of 250,000 shares of Series A Convertible Preferred Stock, par value $0.01 per share (the “Series A Preferred Stock”) for $100.00 per share for gross proceeds of approximately $25.0 million to Maewyn FVR II LP (the “Maewyn Purchaser”), Rebound Investment, LP and Petrus Special Situations Fund, L.P. (collectively, the “Purchasers”).”

FrontView REIT, Inc. entered into Distribution Agreement with J.P. Morgan Securities LLC, BofA Securities, Inc., B. Riley Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Huntington Securities, Inc., Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC (a valued at up to $75,000,000 (effective 2026-02-27).

“On February 27, 2026, FrontView REIT, Inc. (the “ Company ”) and FrontView Operating Partnership, the Company’s operating partnership (the “ OP ”), entered into a distribution agreement (as it may be amended from time to time, the “ Distribution Agreement ”) with each of J.P. Morgan Securities LLC, BofA Securities, Inc., B. Riley Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Huntington Securities, Inc., Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC (and certain of their respective affiliates or agents and other parties named below), acting in their capacity as Agents (as described below), each of J.P. Morgan Securities LLC, BofA Securities, Inc., B. Riley Securities, Inc., Huntington Securities, Inc., Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, Nomura Securities International, Inc. (acting through BTIG, LLC as its agent), RBC Capital Markets, LLC,”

Hashdex Nasdaq CME Crypto Index ETF amended Amendment #1 with Virtu Americas LLC (effective 2026-02-24).

“On February 24, 2026, Hashdex Nasdaq CME Crypto Index ETF (the “Trust”) and Hashdex Asset Management Ltd., as sponsor of the Trust (the “Sponsor”), entered into Amendment #1 (the “Amendment”) to the Authorized Participant Agreement, dated as of January 14, 2025 (the “AP Agreement”), with Virtu Americas LLC (“Virtu”).”

Roman DBDR Acquisition Corp. II entered into Business Combination Agreement with ThomasLloyd Climate Solutions B.V., holders of ThomasLloyd's outstanding ordinary shares, TL Topco PLC, ThomasLloyd Climate Solutions Merger Sub (effective 2026-02-27).

“On February 27, 2026, Roman DBDR Acquisition Corp. II, a Cayman Islands exempted company (“ Roman ”), ThomasLloyd Climate Solutions B.V., a private company with limited liability ( besloten vennootschap met beperkte aansprakelijkheid ), with its corporate seat in Amsterdam, the Netherlands (“ ThomasLloyd ”), and each of the holders of ThomasLloyd’s outstanding ordinary shares as named in the Business Combination Agreement (the “ Sellers ”), entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “ Business Combination Agreement ”).”

VisionWave Holdings, Inc. amended First Amendment with Matania (Mati) Moskovich, C.M. Composite Materials Ltd. (effective 2026-02-26).

“On February 26, 2026, the Company entered into the First Amendment (the “Amendment”) to that certain Investment and Share Purchase Agreement, dated as of February 20, 2026 (the “SPA”), by and among the Company (“Buyer”), Matania (Mati) Moskovich (the “Seller”), and, solely for purposes of acknowledgment and certain covenants therein, C.M. Composite Materials Ltd., an Israeli limited liability company (the “CM Company”).”

VisionWave Holdings, Inc. entered into Letter Agreement with YA II PN, Ltd. valued at $20,000,000 (effective 2026-02-26).

“On February 26, 2026, VisionWave Holdings Inc. (the “Company”) entered into a Letter Agreement (the “Letter Agreement”) with YA II PN, Ltd. (the “Investor”), pursuant to which the Investor agreed to provide the Company with a $20,000,000 senior loan”

CNL Strategic Residential Credit, Inc. amended Amendment No. 1 to the Expense Support and Conditional Reimbursement Agreement with Residential Credit Manager, LLC and Balbec Capital Management, L.P. (effective 2026-01-01).

“On February 27, 2026, the Company entered into Amendment No. 1 to the Expense Support and Conditional Reimbursement Agreement (the “First Amendment”) amending that certain the Expense Support and Conditional Reimbursement Agreement by and among the Company, Residential Credit Manager, LLC and Balbec Capital Management, L.P. dated May 6, 2025 (the “Expense Support Agreement”). The First Amendment extends the period where the Expense Support Amount obligation may be equal to any negative Available Operating Funds (as defined in the Expense Support Agreement) from December 31, 2025 to December 31, 2026. The First Amendment has an effective date of January 1, 2026.”

Atrium Therapeutics, Inc. entered into Transition Services Agreement with Avidity Biosciences, Inc. valued at Company and Avidity entered into a Transition Services Agreement pursuant to which Avidity will prov (effective 2026-02-26).

“☐ Item 1.01 Entry into a Material Definitive Agreement On February 26, 2026, Avidity Biosciences, Inc. (“Avidity”) completed the previously announced separation of all of its assets and liabilities exclusively related to its early stage precision cardiology programs, including ATR 1086 and ATR 1072, and certain collaboration agreements, consisting of those with Bristol-Myers Squibb Company and Eli Lilly and Company, into a separate, independent publicly traded company (the “Separation”), Atrium Therapeutics, Inc.”

Atrium Therapeutics, Inc. entered into Amended and Restated License Agreement with Avidity Biosciences, Inc. valued at Company entered into an Amended and Restated License Agreement with Avidity, amending the original l (effective 2026-02-26).

“On February 26, 2026, the Company entered into an Amended and Restated License Agreement (“Amended and Restated License Agreement”) with Avidity amending the original license agreement between the Company and Avidity, dated October 25, 2025 (the “Original License Agreement”), pursuant to which the Company granted to Avidity certain exclusive and non-exclusive licenses under the Company’s platform technology and other intellectual property, and Avidity granted to the Company certain exclusive and non-exclusive licenses under certain intellectual property owned or controlled by Avidity and its subsidiaries following the Separation, as further described in the section of the Information Statement (the “Information Statement”) entitled “Business—Intellectual Property—RemainCo License Agreement” filed as Exhibit 99.1 to Amendment No. 2 to the Registration Statement on Form 10 (the “Form 10”), filed by the Company with the Securities and Exchange Commission on February 17, 2026.”

Clearthink 1 Acquisition Corp. entered into Administrative Services Agreement with ClearThink 1 Sponsor LLC valued at Agreement for administrative services provided by sponsor to the company. (effective 2026-02-25).

“An Administrative Services Agreement, dated February 25, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference;”

Clearthink 1 Acquisition Corp. entered into Investment Management Trust Agreement with Equiniti Trust Company, LLC valued at Trust agreement for proceeds from IPO held in trust until business combination. (effective 2026-02-25).

“An Investment Management Trust Agreement, dated February 25, 2026, by and between the Company and Equiniti Trust Company, LLC, as trustee, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference;”

Clearthink 1 Acquisition Corp. entered into Registration Rights Agreement with ClearThink 1 Sponsor LLC and certain other security holders valued at Registration rights granted to sponsor and certain security holders. (effective 2026-02-25).

“A Registration Rights Agreement, dated February 25, 2026, by and among the Company, the Sponsor and certain other security holders named therein, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference;”

Clearthink 1 Acquisition Corp. entered into Insider Letter Agreement with ClearThink 1 Sponsor LLC valued at Agreement with sponsor, officers, directors, and underwriter regarding lock-up and other obligations (effective 2026-02-25).

“An Insider Letter Agreement, dated February 25, 2026, by and between the Company and ClearThink 1 Sponsor LLC (the “Sponsor”), each of its officers and directors, and DBC, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference (the “Insider Letter Agreement”);”

Clearthink 1 Acquisition Corp. entered into Rights Agreement with VStock Transfer, LLC valued at Agreement governing rights attached to Units, each right entitling holder to receive one-fifth of an (effective 2026-02-25).

“A Rights Agreement, dated February 25, 2026, by and between the Company and VStock Transfer, LLC, as rights agent, a copy of which includes the form of rights certificate, is attached as Exhibit 4.1 hereto and incorporated herein by reference;”

Clearthink 1 Acquisition Corp. entered into Underwriting Agreement with D. Boral Capital LLC valued at IPO of 12,500,000 units at $10.00 per unit, gross proceeds $125,000,000 (effective 2026-02-23).

“An Underwriting Agreement, dated February 23, 2026, by and between the Company and D. Boral Capital LLC (“DBC”), acting as representative of the underwriters named therein, which contains customary representations and warranties and indemnification of the underwriters by the Company and is attached as Exhibit 1.1 hereto and incorporated herein by reference;”

MOZAYYX Acquisition Corp. entered into Indemnity Agreements with each director and executive officer of the Company valued at Indemnity agreements with directors and officers (effective 2026-02-24).

“Indemnity Agreements, dated February 24, 2026 (each, an “ Indemnity Agreement ”), by and among the Company and each director and executive officer of the Company, a form of which is attached as Exhibit 10.6 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Letter Agreement with MOZAYYX Acquisition Sponsor LLC valued at Letter agreement among Company, officers, directors and sponsor (effective 2026-02-24).

“A Letter Agreement, dated February 24, 2026 (the “ Letter Agreement ”), by and among the Company, its officers, its directors and the Sponsor, a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Representative Private Placement Warrants Purchase Agreement with Cantor Fitzgerald & Co. valued at Private placement warrants purchase agreement with representative (effective 2026-02-24).

“A Private Placement Warrants Purchase Agreement, dated February 24, 2026 (the “ Representative Private Placement Warrants Purchase Agreement ”), by and between the Company and the Representative, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Sponsor Private Placement Warrants Purchase Agreement with MOZAYYX Acquisition Sponsor LLC valued at Private placement warrants purchase agreement with sponsor (effective 2026-02-24).

“A Private Placement Warrants Purchase Agreement, dated February 24, 2026 (the “ Sponsor Private Placement Warrants Purchase Agreement ”), by and between the Company and MOZAYYX Acquisition Sponsor LLC, a Delaware limited liability company (the “ Sponsor ”), a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Registration Rights Agreement with certain security holders valued at Registration rights agreement with security holders (effective 2026-02-24).

“A Registration Rights Agreement, dated February 24, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company valued at Trust agreement for IPO proceeds held in trust (effective 2026-02-24).

“An Investment Management Trust Agreement, dated February 24, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Warrant Agreement with Continental Stock Transfer & Trust Company valued at Warrant Agent agreement for warrants issued in IPO (effective 2026-02-24).

“A Warrant Agreement, dated February 24, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Underwriting Agreement with Cantor Fitzgerald & Co. valued at underwriting of 30,000,000 units at $10.00/unit for gross proceeds of $300,000,000 (effective 2026-02-24).

“the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s Registration Statements: ● An Underwriting Agreement, dated February 24, 2026, by and between the Company and Cantor Fitzgerald & Co., as representative of the underwriters (the “ Representative ”), a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.”

TRG Latin America Acquisitions Corp. entered into Private Placement Units Purchase Agreement with TRG Latin America Acquisitions LLC (effective 2026-02-25).

“● A Private Placement Units Purchase Agreement, dated February 25, 2026 (the “Private Placement Units Purchase Agreement”), by and between the Company and TRG Latin America Acquisitions LLC (the “Sponsor”), a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.”

TRG Latin America Acquisitions Corp. entered into Registration Rights Agreement with certain security holders (effective 2026-02-25).

“● A Registration Rights Agreement, dated February 25, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.”

TRG Latin America Acquisitions Corp. entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-25).

“● An Investment Management Trust Agreement, dated February 25, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.”

TRG Latin America Acquisitions Corp. entered into Rights Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-25).

“● A Rights Agreement, dated February 25, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as Share Rights agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference.”

TRG Latin America Acquisitions Corp. entered into Underwriting Agreement with Santander US Capital Markets LLC (effective 2026-02-25).

“● An Underwriting Agreement, dated February 25, 2026, by and between the Company and Santander US Capital Markets LLC, as the sole underwriter, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.”

LISATA THERAPEUTICS, INC. amended Term Sheet Amendment with Kuva Labs Inc. (effective 2026-02-27).

“On February 27, 2026, Lisata and Kuva entered into an amendment to the Term Sheet (the “Term Sheet Amendment”), whereby the parties agreed to extend the expiration date of the Term Sheet to March 7, 2026.”

PRIMEENERGY RESOURCES CORP amended Fifth Amendment with Citibank, N.A., as administrative agent, and the lenders party thereto (effective 2026-02-24).

“On February 24, 2026, PrimeEnergy Resources Corporation (the “Company”), as borrower, entered into a Fifth Amendment (the “Amendment”) to its Fourth Amended and Restated Credit Agreement, dated as of July 5, 2022 (as previously amended, the “Credit Agreement”), with Citibank, N.A., as administrative agent, and the lenders party thereto.”

Viskase Holdings, Inc. amended Eighth Amendment to the Section 382 Rights Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-27).

“On February 27, 2026, Enzon Pharmaceuticals, Inc. (the “ Company ”) entered into the Eighth Amendment to the Section 382 Rights Agreement (the “ Eighth Amendment ”), which amends the Section 382 Rights Agreement, dated as of August 14, 2020 (the “ Rights Agreement ”), by and between the Company and Continental Stock Transfer & Trust Company, as rights agent.”

Birchtech Corp. entered into Underwriting Agreement with Lake Street Capital Markets, LLC, as representative of the several underwriters named therein valued at approximately $13.1 million (effective 2026-02-25).

“On February 25, 2026, Birchtech Corp. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Lake Street Capital Markets, LLC, as representative of the several underwriters named therein (collectively, the “Underwriters”), relating to the public offering of 6,250,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price per share of $2.40 (the “Offering Price”).”

ODYSSEY MARINE EXPLORATION INC amended Restated JV Agreement with Capital Latinoamericano, S.A. de C.V. and Phosagmex, S.A.P.I. de C.V. (effective 2026-02-27).

“On February 27, 2026, the Company, certain of its affiliates, CapLat, and Phosagmex entered into an amended and restated JV Agreement (the “Restated JV Agreement”).”

ROYAL CARIBBEAN CRUISES LTD entered into Fifth Supplemental Indenture dated February 27, 2026 with The Bank of New York Mellon Trust Company, N.A. valued at Supplement to Base Indenture dated July 31, 2006 governing the 4.750% Senior Notes due 2033 and the (effective 2026-02-27).

“The Notes were issued by the Company pursuant to an indenture, dated as of July 31, 2006 (the “Base Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A. as trustee (the “Trustee”), as supplemented by a Fifth Supplemental Indenture, dated February 27, 2026, between the Company and the Trustee (the “Fifth Supplemental Indenture” and, together with the Base Indenture, the “Indenture”).”

ROYAL CARIBBEAN CRUISES LTD entered into Underwriting Agreement for 4.750% Senior Notes due 2033 and 5.250% Senior Notes due 2038 with J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and PNC Capital Markets LLC valued at Aggregate principal amount of $2,500,000,000 ($1,250,000,000 4.750% Senior Notes due 2033 and $1,250 (effective 2026-02-27).

“On February 27, 2026, Royal Caribbean Cruises Ltd. (the “Company”) completed its previously announced offering of $1,250,000,000 aggregate principal amount of 4.750% Senior Notes due 2033 (the “2033 Notes”) and $1,250,000,000 aggregate principal amount of the Company’s 5.250% Senior Notes due 2038 (the “2038 Notes” and, together with the 2033 Notes, the “Notes”), pursuant to an underwriting agreement, dated as of February 12, 2026 (the “Underwriting Agreement”), among the Company and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and PNC Capital Markets LLC, as representatives of the several underwriters named therein.”

Gentherm Inc amended First Amendment to Second Amended and Restated Credit Agreement with Bank of America, N.A. valued at Amendment permits up to $400 million additional term indebtedness, releases certain borrower/guarant (effective 2026-02-24).

“Item 1.01 Entry into a Material Definitive Agreement. First Amendment to Second Amended and Restated Credit Agreement On February 24, 2026, Gentherm Incorporated (“Gentherm”), together with the other borrowers and guarantors party thereto, entered into that certain First Amendment to Second Amended and Restated Credit Agreement (the “First Amendment”), with the lenders party thereto and Bank of America, N.A., as administrative agent (in such capacity, the “Administrative Agent”), which First Amendment amends that certain Second Amended and Restated Credit Agreement, dated as of June 10, 2022, by and among Gentherm, as a borrower, the other borrowers from time to time party thereto, the lenders from time to time party thereto and the Administrative Agent.”

WESCO INTERNATIONAL INC entered into Indenture, dated as of February 27, 2026, among WESCO Distribution, Inc., the guarantors named therein and U.S. Bank Trust Company, National Association, as trustee with U.S. Bank Trust Company, National Association, as trustee valued at $1.5 billion aggregate principal amount of 5.250% Senior Notes due 2031 and 5.500% Senior Notes due (effective 2026-02-27).

“On February 27, 2026, WESCO Distribution, Inc. (the “Issuer” or “Wesco Distribution”), a wholly owned subsidiary of WESCO International, Inc. (the “Company” or “WESCO”), completed its previously announced offering (the “Offering”) to eligible purchasers of $650 million aggregate principal amount of 5.250% senior notes due 2031 (the “5-Year Notes”) and $850 million aggregate principal amount of 5.500% senior notes due 2034 (the “8-Year Notes” and, together with the 5-Year Notes, the “Notes”).”

STONERIDGE INC entered into Cooperation Agreement with 22NW Fund, LP, 22NW, LP, 22NW Fund GP, LLC, 22NW GP, Inc., and Aron R. English (effective 2026-02-26).

“On February 26, 2026, Stoneridge, Inc., an Ohio corporation (the “Company”), entered into a Cooperation Agreement (the “Cooperation Agreement”) with 22NW Fund, LP, a Delaware limited partnership, 22NW, LP, a Delaware limited partnership, 22NW Fund GP, LLC, a Delaware limited liability company, 22NW GP, Inc., a Delaware S corporation, and Aron R. English (collectively, “22NW” or the “Investor Group”).”

CNX Resources Corp entered into Indenture with the subsidiary guarantors party thereto and UMB Bank, N.A., as trustee valued at $500,000,000 (effective 2026-02-26).

“On February 26, 2026, CNX Resources Corporation (the “Company”) completed a private offering (the “Notes Offering”) of $500,000,000 aggregate principal amount of 5.875% senior notes due 2034 (the “Notes”), along with the related guarantees of the Notes (the “Guarantees”). The Notes and Guarantees were issued pursuant to an indenture (the “Indenture”), dated February 26, 2026, among the Company, the subsidiary guarantors party thereto and UMB Bank, N.A., as trustee (the “Trustee”).”

PLUG POWER INC entered into Purchase and Sale Agreement and Joint Escrow Instructions with Stream US Data Centers, LLC valued at between $132.5 million and $142.0 million (effective 2026-02-24).

“On February 24, 2026, Plug Power Inc., a Delaware corporation, and its wholly owned subsidiary, Plug Project Holding Co., LLC, a Delaware limited liability company (together with Plug Power Inc., the “Company”), entered into a Purchase and Sale Agreement and Joint Escrow Instructions (the “Agreement”) with Stream US Data Centers, LLC, a Texas limited liability company (“Purchaser”), pursuant to which the Company agreed to sell to Purchaser certain real property and related assets located in the Town of Alabama, Genesee County, New York (the “Property”). The Company will be entitled to receive a purchase price ranging between $132.5 million and $142.0 million, depending on the timing of closing and the removal status of certain hydrogen storage spheres located on the Property.”

TELEDYNE TECHNOLOGIES INC amended First Amendment (effective 2026-02-25).

“On February 25, 2026, Teledyne and the other parties to the Credit Agreement entered into a First Amendment to the Credit Agreement (the "First Amendment").”

CENTERPOINT ENERGY INC entered into Purchase Agreement with the initial purchasers valued at $650,000,000 aggregate principal amount of 2.875% Convertible Senior Notes due 2029 (effective 2026-02-23).

“The Notes were sold under a purchase agreement (the “Purchase Agreement”) dated February 23, 2026 among the Company and the initial purchasers (the “Initial Purchasers”) party thereto.”

CENTERPOINT ENERGY INC entered into Indenture with The Bank of New York Mellon Trust Company, National Association valued at $650,000,000 aggregate principal amount of 2.875% Convertible Senior Notes due 2029 (effective 2026-02-26).

“The Company issued the Notes pursuant to an Indenture (the “Indenture”), dated as of February 26, 2026 by and between the Company and The Bank of New York Mellon Trust Company, National Association, as trustee (the “Trustee”).”

APPLIED OPTOELECTRONICS, INC. entered into Equity Distribution Agreement with Raymond James & Associates, Inc. and Needham & Company, LLC valued at up to $250 million (effective 2026-02-26).

“On February 26, 2026, Applied Optoelectronics, Inc. (the “Company”) entered into an Equity Distribution Agreement (the “Agreement”) with Raymond James & Associates, Inc. and Needham & Company, LLC (collectively, the “Sales Agents”) pursuant to which the Company may issue and sell shares of the Company’s common stock, par value $0.001 per share (the “Shares”) having an aggregate offering price of up to $250 million from time to time through the Sales Agents.”

NISSAN AUTO LEASING LLC II entered into Indenture with U.S. Bank valued at $1,250,000,000 (effective 2026-02-26).

“On the Closing Date, the Issuing Entity caused the issuance, pursuant to an Indenture, dated as of the Closing Date (the “Indenture”), by and between the Issuing Entity, as issuer, and U.S. Bank, as indenture trustee (the “Indenture Trustee”), of $111,000,000 aggregate principal amount of the Class A-1 Asset Backed Notes, $239,940,000 aggregate principal amount of the Class A-2a Asset Backed Notes, $240,000,000 aggregate principal amount of the Class A-2b Asset Backed Notes, $479,940,000 aggregate principal amount of the Class A-3 Asset Backed Notes, $78,860,000 aggregate principal amount of the Class A-4 Asset Backed Notes, $47,640,000 aggregate principal amount of the Class B Asset Backed Notes and $52,620,000 aggregate principal amount of the Class C Asset Backed Notes (collectively, the “Notes”)”